Research article · 15 May 2026
Short communicationPublished 11 May 2021
Study of histopathological features of invasive breast carcinoma in relation to hormone receptor status
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Breast cancer is the most common cancer in urban Indian women with age adjusted rate of 25.8 and mortality of 12.7 per 1,00,000 women. Prognosis is greatly determined by clinicopathological and molecular characteristics of the tumor. Hormone receptor status evaluation has become a critical determinant for classification and management of breast cancer. Estrogen receptor (ER) status has emerged as important criteria in determining the prognosis and treatment as it plays a major role in tumor metastasis. Aim of this study is to assess the relationship between morphological features and hormone receptor status of invasive breast carcinoma. This is a retrospective study of 25 cases of breast carcinoma diagnosed between July2020-December2020 in the department of pathology, JSS Medical college, Mysore. The tumors were categorized into ER+PR+ (36%), ER+PR-(20%), ER-PR+ (0%), ER-PR-(44%). Well differentiated low grade invasive carcinomas were frequently ER+PR+ whereas high grade infiltrating carcinomas were mainly ER-PR-. Tumor necrosis, lymphovascular invasion, lymph node involvement, high tumor grade were more frequently associated with ER-PR- status. Histopathological evaluation and grading of breast cancer substantiated by hormone receptor status forms a reliable tool in determining treatment modality and prognosis of the patient.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Oncology Translational Research.
Research article · 15 Dec 2025
Cardiac Substructure Analysis of Radiation-associated Cardiac Disease in Thoracic Malignancy Patients
Brief report · 29 Nov 2025
CDx: Navigating Global Regulations for Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Oncology Translational Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Chandana Ullas”
- BylineArticles whose byline prints “Nandini Manoli”
